COVID-19Updates See latest Press Relases Celularity Appoints Geoffrey Shiu Fei Ling, M.D., Ph.D. to its Board of Directors 7 Sep 2023 10 Minutes 0 460 ... Celularity Announces Multi-Year Research Collaboration Services Agreement With Regeneron 29 Aug 2023 6 Minutes 0 464 ... Letter to shareholders 3 Aug 2023 7 Minutes 0 39 Dear Shareholders: As I am certain our Celularity shareholders are aware, the sharp devaluation in share prices, industry-wide, has created tremendous anxiety as well as considerable headwinds in capital raising... Celularity Inc. Announces $3 Million Registered Direct Offering 27 Jul 2023 6 Minutes 0 455 ... Celularity and Verséa Ophthalmics Announce Exclusive U.S. Commercialization Agreement to Distribute Biovance® and Biovance® 3L Ocular for Ophthalmic Applications 27 Jul 2023 5 Minutes 0 456 ... Load more
Celularity Appoints Geoffrey Shiu Fei Ling, M.D., Ph.D. to its Board of Directors 7 Sep 2023 10 Minutes 0 460 ...
Celularity Announces Multi-Year Research Collaboration Services Agreement With Regeneron 29 Aug 2023 6 Minutes 0 464 ...
Letter to shareholders 3 Aug 2023 7 Minutes 0 39 Dear Shareholders: As I am certain our Celularity shareholders are aware, the sharp devaluation in share prices, industry-wide, has created tremendous anxiety as well as considerable headwinds in capital raising...
Celularity and Verséa Ophthalmics Announce Exclusive U.S. Commercialization Agreement to Distribute Biovance® and Biovance® 3L Ocular for Ophthalmic Applications 27 Jul 2023 5 Minutes 0 456 ...
